2m 2m 2m 2m 2m 2m 2m
STOKE THERAP (STOK)
NASDAQ
$31.97-$0.32 (-0.99%)
Price as of Aug 21, 2026 7:30 PM EDT- $2.1BMarket Cap
- 65.08%1-Year Change
- BiotechnologyIndustry
STOKE THERAP (STOK)
$31.97-$0.32 (-0.99%)
STOK | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $32.29 | ||
Change | +$0.89 (+2.83%) | ||
Open | $31.76 | ||
High | $32.77 | ||
Low | $31.52 | ||
Previous Close | $31.40 | ||
Volume | 1,274,422 | ||
30-Day Average Volume | 892,606 | ||
1-Week Change | 3.26% | ||
1-Month Change | 12.08% | ||
1-Year Change | 65.08% | ||
3-Year Change | 478.67% | ||
5-Year Change | 29.68% | ||
Fundamentals | |||
Shares Outstanding | 64.5M | ||
Total Assets | $394.0M | ||
Market Cap | $2.1B | ||
Enterprise Value | $2.0B | ||
Period: QTR TTM FY | |||
Revenue | $9.3M | ||
Net Income | -$61.6M | ||
Free Cash Flow | -$58.6M | ||
EBIT | -$61.6M | ||
EBITDA | -$61.1M | ||
Net Working Capital | $280.6M | ||
EPS | -$0.93 | ||
Enterprise Value/EBITDA | -32 | ||
Enterprise Value/Revenue | 212 | ||
P/B | 6 | ||
P/E | -35 | ||
PEG | 2 | ||
Price/Free Cash Flow | -36 | ||
Price/Operating Cash Flow | -37 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue